NORTH-REG Dwell-Time Study

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2030

Conditions
Side Effect of Drug
Interventions
DRUG

Bacillus Calmette Guerin

The same dose of the drug will be given in both arms but the dwell-time will be adjusted for the subjects in the intervention arm according to the grading of side effects given by the study algorithm.

Trial Locations (11)

101

Landspitali University Hospital, Reykjavik

2100

Department of Urology, Rigshospitalet, Copenhagen

4000

Zealand University Hospital, Roskilde

5000

Odense University Hospital, Odense

7400

Regional Hospital Gødstrup, Herning

8200

Aarhus University Hospital, Aarhus

9100

Department of Urology, Aalborg University Hospital, Aalborg

Unknown

Herlev Hospital, Herlev

sw 413 45

PO Sahlgrenska Universitetssjukhuset, Gothenburg

701 85

Örebro University Hospital, Örebro

141-86

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Herlev Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Regional Hospital West Jutland

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Zealand University Hospital

OTHER

collaborator

Landspitali University Hospital

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Region Örebro County

OTHER

collaborator

Karolinska University Hospital

OTHER

lead

Jørgen Bjerggaard Jensen

OTHER